These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18648179)

  • 1. Hepatotoxicity caused by both tacrolimus and cyclosporine after living donor liver transplantation.
    Taniai N; Akimaru K; Ishikawa Y; Kanada T; Kakinuma D; Mizuguchi Y; Mamada Y; Yoshida H; Tajiri T
    J Nippon Med Sch; 2008 Jun; 75(3):187-91. PubMed ID: 18648179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus therapy causes hepatotoxicity in patients with a history of liver disease.
    Ko MS; Choi YH; Jung SH; Lee JS; Kim HS; Lee CH; Kim SG
    Int J Clin Pharmacol Ther; 2015 May; 53(5):363-71. PubMed ID: 25740263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of sirolimus in combination with cyclosporine against chronic rejection in a pediatric liver transplant patient.
    Shinke H; Hashi S; Kinoshita R; Taniguchi R; Sugimoto M; Matsubara K; Ogawa E; Sonoda M; Takada N; Yoshizawa A; Ogawa K; Okamoto S; Uemoto S; Masuda S
    Biol Pharm Bull; 2013; 36(7):1221-5. PubMed ID: 23676788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy].
    Kuramitsu S; Iguchi T; Ninomiya M; Yamashita Y; Harimoto N; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Kawanaka H; Ikeda T; Furuta T; Tamada R; Maehara Y
    Fukuoka Igaku Zasshi; 2014 Mar; 105(3):79-83. PubMed ID: 25000660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity.
    Mesar I; Kes P; Hudolin T; Basic-Jukic N
    Ren Fail; 2013; 35(10):1434-5. PubMed ID: 24028307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset acute rejection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Tamura S; Keneko J; Matsui Y; Hasegawa K; Makuuchi M
    World J Gastroenterol; 2006 Nov; 12(41):6674-7. PubMed ID: 17075982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
    Kanzler S; Lohse AW; Schirmacher P; Hermann E; Otto G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1996 Feb; 34(2):128-31. PubMed ID: 8659188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Pure Red Cell Aplasia Caused by Tacrolimus After Living-Donor Liver Transplant.
    Watanabe S; Sakamoto R; Yamamoto H; Imaya M; Yamashita T; Anann T; Nakamura K
    Exp Clin Transplant; 2020 Dec; 18(7):838-841. PubMed ID: 31724928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.
    Ferjani H; El Arem A; Bouraoui A; Achour A; Abid S; Bacha H; Boussema-Ayed I
    J Physiol Biochem; 2016 Jun; 72(2):133-44. PubMed ID: 26746208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus-Induced Cholestatic Hepatitis in a Patient With Liver Transplant.
    González-Diéguez ML; Viso Vidal D; Mendoza Pacas GE; Houghton RF
    Transplantation; 2018 Oct; 102(10):e454-e456. PubMed ID: 29979348
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).
    Trotter JF; Wachs M; Bak T; Trouillot T; Stolpman N; Everson GT; Kam I
    Liver Transpl; 2001 Apr; 7(4):343-51. PubMed ID: 11303295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
    Ganschow R; Albani J; Grabhorn E; Richter A; Burdelski M
    Pediatr Transplant; 2006 Mar; 10(2):220-4. PubMed ID: 16573611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.